Results 221 to 230 of about 715,934 (277)
Carcinoid Complexity: A Syndrome Revealing Lung Tumor and Heart Disease
Sofia R. Lopes +3 more
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Management of carcinoid heart disease
Current Problems in CancerCarcinoid Heart Disease (CaHD) is defined as the constellation of all cardiac manifestations that occur in patients with carcinoid tumors. Cardiac manifestations are generally due to the paraneoplastic effects of vasoactive substances secreted by carcinoid tumors. These primarily cause cardiac valve dysfunction and resultant heart failure.
Madelaine Hack +1 more
openaire +3 more sources
Heart, 2017 Rare neuroendocrine tumours (NETs) that most commonly arise in the gastrointestinal tract can lead to carcinoid syndrome and carcinoid heart disease. Patients with carcinoid syndrome present with vasomotor changes, hypermotility of the gastrointestinal system, hypotension and bronchospasm.
Arvind Dasari +5 more
openaire +2 more sources
Heart, 2023
Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited.
G. Suc +15 more
semanticscholar +1 more source
Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited.
G. Suc +15 more
semanticscholar +1 more source
Carcinoid heart disease: another step into the knowledge of a rare disease
Heart, 2023With an incidence of 1/100 000 in the general population, carcinoid tumours are rare neuroendocrine malignancies (NETs). Mostly originating from the enterochromaffin cells of the gastrointestinal tract, they usually grow slowly over the years, secreting ...
A. Pavon, M. Guglielmo
semanticscholar +1 more source
Current Treatment Options in Cardiovascular Medicine, 2000
Carcinoid syndrome originates from metastatic carcinoid tumors localized in the gastrointestinal system, pancreas, biliary vessels, bronchi, ovaries, and testes; it is characterized by flushing, telangiectasias, diarrhea, bronchoconstriction, and fibrous endocardial plaques in the heart.
Vera H. Rigolin, Di Luzio S
openaire +3 more sources
Carcinoid syndrome originates from metastatic carcinoid tumors localized in the gastrointestinal system, pancreas, biliary vessels, bronchi, ovaries, and testes; it is characterized by flushing, telangiectasias, diarrhea, bronchoconstriction, and fibrous endocardial plaques in the heart.
Vera H. Rigolin, Di Luzio S
openaire +3 more sources
Cardiology in Review, 2012
Carcinoid tumors are rare, indolent neuroendocrine tumors that are often associated with a syndrome characterized by episodic flushing, secretory diarrhea, bronchospasm, and hypotension-the carcinoid syndrome. Cardiac involvement occurs in one-half to two-thirds of patients with carcinoid syndrome and is associated with a worse clinical outcome ...
Wilbert S. Aronow +2 more
openaire +3 more sources
Carcinoid tumors are rare, indolent neuroendocrine tumors that are often associated with a syndrome characterized by episodic flushing, secretory diarrhea, bronchospasm, and hypotension-the carcinoid syndrome. Cardiac involvement occurs in one-half to two-thirds of patients with carcinoid syndrome and is associated with a worse clinical outcome ...
Wilbert S. Aronow +2 more
openaire +3 more sources
Carcinoid heart disease: a potentially fatal complication of carcinoid syndrome
BMJ Case Reports, 2023Carcinoid heart disease is a unique and serious cardiac complication of the neuroendocrine tumour that affects the right side of the heart, especially the tricuspid and pulmonic valves, eventually causing right heart failure. We present a middle-aged man
Mustafa Bdiwi +6 more
semanticscholar +1 more source
International Journal of Cardiology, 2008
The carcinoid syndrome is usually evident when enterochromaffin (EC) cell-derived neuroendocrine tumors (carcinoids) metastasize to the liver. In addition to carcinoid symptomatology, about 40% of patients exhibit carcinoid heart disease (CHD) with fibrotic endocardial plaques and associated heart valve dysfunction. The mechanism behind CHD development
Øyvind Hauso +5 more
openaire +3 more sources
The carcinoid syndrome is usually evident when enterochromaffin (EC) cell-derived neuroendocrine tumors (carcinoids) metastasize to the liver. In addition to carcinoid symptomatology, about 40% of patients exhibit carcinoid heart disease (CHD) with fibrotic endocardial plaques and associated heart valve dysfunction. The mechanism behind CHD development
Øyvind Hauso +5 more
openaire +3 more sources
Carcinoid Heart Disease: a Review
Current Oncology Reports, 2021The development of carcinoid heart disease (CHD) is a fibrotic complication of neuroendocrine neoplasms (NEN) which is associated with a poor prognosis. This review aims to summarise the clinical features, investigations and management of this condition.CHD can affect up to 50% of NET patients with carcinoid syndrome.
Faidon-Marios Laskaratos +2 more
openaire +3 more sources